A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy. by Rojas, J, Fernandez, I, Pastor, J, Maclaren, R, Ramkissoon, Y, Harsum, S, Charteris, D, Van Meurs, J, Amarakoon, S, Ruiz-Moreno, J, Rocha-Sousa, A, Brion, M, Carracedo, A

Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables. by Rojas, J, Fernandez, I, Pastor, J, Maclaren, R, Ramkissoon, Y, Harsum, S, Charteris, D, Van Meurs, J, Amarakoon, S, Garcia-Arumi, J, Ruiz-Moreno, J, Rocha-Sousa, A, Brion, M, Carracedo, A

The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy. by Pastor-Idoate, S, Rodríguez-Hernández, I, Rojas, J, Fernández, I, García-Gutiérrez, M, Ruiz-Moreno, J, Rocha-Sousa, A, Ramkissoon, Y, Harsum, S, Maclaren, R, Charteris, D, Vanmeurs, J, González-Sarmiento, R, Pastor, J

The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project. by Pastor-Idoate, S, Rodriguez-Hernández, I, Rojas, J, Fernández, I, García-Gutierrez, M, Ruiz-Moreno, J, Rocha-Sousa, A, Ramkissoon, Y, Harsum, S, Maclaren, R, Charteris, D, van Meurs, J, González-Sarmiento, R, Pastor, J